Overview A Study in Men With Benign Prostatic Hyperplasia Status: Terminated Trial end date: 2011-10-01 Target enrollment: Participant gender: Summary The purpose of the study is to determine whether LY500307 helps symptoms of Benign Prostatic Hyperplasia (BPH) Phase: Phase 2 Details Lead Sponsor: Eli Lilly and Company